Literature DB >> 3421948

Isolation and sequence of a cDNA for human pro-(cathepsin L).

S Gal1, M M Gottesman.   

Abstract

The major excreted protein (MEP) of malignantly transformed mouse fibroblasts is the precursor to an acid proteinase with enzymic specificity similar to that of human cathepsin L. By cross-hybridization with a mouse MEP sequence, cDNA clones of the human form of MEP in an SV40 expression vector were isolated. A 1.6 kb cDNA showed 70% deduced amino acid sequence identity with mouse MEP. The deduced amino acid sequence of the cloned human MEP was the same, except for two amino acids, as the N-terminal sequence of mature human cathepsin L, thereby establishing that human MEP is human pro-(cathepsin L). Use of this human pro-(cathepsin L) cDNA clone allowed the detection of a 1.6-1.8 kb pro-(cathepsin L) mRNA in human cells which was not detected with a mouse pro-(cathepsin L) probe.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421948      PMCID: PMC1149292          DOI: 10.1042/bj2530303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes.

Authors:  M S Rabin; P J Doherty; M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Thiol proteases. Comparative studies based on the high-resolution structures of papain and actinidin, and on amino acid sequence information for cathepsins B and H, and stem bromelain.

Authors:  I G Kamphuis; J Drenth; E N Baker
Journal:  J Mol Biol       Date:  1985-03-20       Impact factor: 5.469

3.  A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides.

Authors:  D Perlman; H O Halvorson
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

4.  Malignant transformation and tumor promoter treatment increase levels of a transcript for a secreted glycoprotein.

Authors:  P J Doherty; L Hua; G Liau; S Gal; D E Graham; M Sobel; M M Gottesman
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

5.  Stimulation of the release of two glycoproteins from mouse 3T3 cells by growth factors and by agents that increase intralysosomal pH.

Authors:  M Nilsen-Hamilton; R T Hamilton; W R Allen; S L Massoglia
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

6.  The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity.

Authors:  S Gal; M M Gottesman
Journal:  Biochem Biophys Res Commun       Date:  1986-08-29       Impact factor: 3.575

7.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

8.  The predominant secreted protein of transformed murine fibroblasts carries the lysosomal mannose 6-phosphate recognition marker.

Authors:  G G Sahagian; M M Gottesman
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

9.  The major excreted protein of transformed fibroblasts is an activable acid-protease.

Authors:  S Gal; M M Gottesman
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

10.  Processing and lysosomal localization of a glycoprotein whose secretion is transformation stimulated.

Authors:  S Gal; M C Willingham; M M Gottesman
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

View more
  15 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes.

Authors:  J Deussing; W Roth; W Rommerskirch; B Wiederanders; K von Figura; C Peters
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

3.  Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana.

Authors:  S J Sanderson; K G Pollock; J D Hilley; M Meldal; P S Hilaire; M A Juliano; L Juliano; J C Mottram; G H Coombs
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

4.  Effect of carbohydrate position on lysosomal transport of procathepsin L.

Authors:  R G Lingeman; D S Joy; M A Sherman; S E Kane
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

5.  Use of a cloned multidrug resistance gene for coamplification and overproduction of major excreted protein, a transformation-regulated secreted acid protease.

Authors:  S E Kane; B R Troen; S Gal; K Ueda; I Pastan; M M Gottesman
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

6.  Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.

Authors:  Didier Jean; Nathalie Guillaume; Raymond Frade
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

7.  Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours.

Authors:  T Kageshita; A Yoshii; T Kimura; K Maruo; T Ono; M Himeno; Y Nishimura
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.

Authors:  Nathalie Guillaume-Rousselet; Didier Jean; Raymond Frade
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

9.  Two distinct gene subfamilies within the family of cysteine protease genes.

Authors:  K M Karrer; S L Peiffer; M E DiTomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  A cysteine protease encoded by the baculovirus Bombyx mori nuclear polyhedrosis virus.

Authors:  T Ohkawa; K Majima; S Maeda
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.